RNA · Atrium Therapeutics, Inc.
$11.57
+0.03 (+0.26%)
At close · Jul 27
Market Cap
$196.54M
Shares
17.11M
Positioning
Sep 18, 2026 · 52 days to expiry · 36 contractsPut / call OI
2.25
Put-heavy positioning
Open interest
2,484
contracts outstanding
Volume
22
traded today
Max pain
$65.00
$53.43 above spot
ATM implied vol
0.3%
market's expected move
Open interest by strike
Calls
Puts
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
105
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 1 | — | 0.3% | 0 | — | — | — | — | — | 0 | |
| 0 | — | 0.3% | 0 | — | — | — | — | — | 40 | |
| 0 | — | 0.3% | 0 | — | — | — | — | — | 15 | |
| 0 | — | 0.3% | 0 | — | $0.05 | — | — | 6 | 38 | |
| 0 | — | 0.3% | 0 | — | — | — | — | — | 142 | |
| 10 | — | 0.3% | 0 | — | — | — | — | — | 572 | |
| 0 | — | 0.3% | 0 | — | — | — | — | — | 22 | |
| 533 | — | 0.3% | 0 | — | — | — | — | — | 24 | |
| 61 | — | 0.3% | 0 | — | — | — | — | — | 36 | |
| 60 | — | 749.4% | 0.795 | — | $0.05 | — | — | 5 | 346 | |
| 93 | 1 | 457.3% | 0.435 | $3.10 | $0.01 | — | — | 10 | 481 | |
| 4 | — | 280.6% | 0.112 | — | — | — | — | — | 3 | |
| 2 | — | 292.5% | 0.119 | — | — | — | — | — | 0 | |
| 0 | — | 308.6% | 0.135 | — | — | — | — | — | 0 | |
| 0 | — | 309.9% | 0.125 | — | — | — | — | — | 0 | |
| 1 | — | 311% | 0.116 | — | — | — | — | — | 0 | |
| 0 | — | 312.2% | 0.106 | — | — | — | — | — | 0 | |
| 0 | — | 311.4% | 0.097 | — | — | — | — | — | 0 | |
About this data
Greeks, implied volatility, open interest and the last price come from the latest daily snapshot and are 15-minute delayed. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
21 filings
21 filers
Visit website
Investor relations